Cargando…
Correction: Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data
Autores principales: | Wolkewitz, Martin, Schumacher, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383344/ https://www.ncbi.nlm.nih.gov/pubmed/28384330 http://dx.doi.org/10.1371/journal.pone.0175660 |
Ejemplares similares
-
Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data
por: Wolkewitz, Martin, et al.
Publicado: (2016) -
Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada
por: Marra, Fawziah, et al.
Publicado: (2014) -
Correction: Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2013) -
Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors
por: Delgado-Rodríguez, Miguel, et al.
Publicado: (2012) -
Correction: Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective Analysis
Publicado: (2014)